CTLA4 and breast cancer: In this study, we have identified a subgroup of patients with lymph-node negative basal-like early-stage breast cancer with excellent outcomes, characterized by high tumor gene expression of CTLA4. Favorable outcomes are seen in patients treated with and without adjuvant chemotherapy.